Screener
Artiva Biotherapeutics, Inc. ARTV Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338029
| Line item | AS OF / JUNE 30,2026 | AS OF / DECEMBER 31,2025 |
|---|---|---|
| Current portion of operating lease liabilities | 3,299 | 3,015 |
| Current portion of financing lease liability | — | 44 |
| Other current liabilities | — | 73 |
| Total current liabilities | 14,581 | 13,087 |
| Operating lease liabilities, net of current portion | 6,550 | 7,883 |
| Total liabilities | 21,131 | 20,970 |
| Commitments and contingencies (Note 10) | ||
| Stockholders’ equity: |
Item 1. Financial Statements
FAQ
- What is Artiva Biotherapeutics, Inc.'s total current liabilities?
- Artiva Biotherapeutics, Inc. (ARTV) reported total current liabilities of $14.58M in Q2 2026.
- How has Artiva Biotherapeutics, Inc.'s total current liabilities changed year-over-year?
- Artiva Biotherapeutics, Inc.'s total current liabilities increased by 35.4% year-over-year, from $10.77M to $14.58M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s total current liabilities?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s total current liabilities has grown at a 3.5% compound annual growth rate (CAGR), from $12.23M to $13.09M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Artiva Biotherapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude